ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

CLSD Clearside Biomedical Inc

1.35
0.03 (2.27%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Clearside Biomedical Inc CLSD NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.03 2.27% 1.35 07:09:02
始値 安値 高値 終値 前日終値
1.34 1.29 1.35 1.31 1.32
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/3020:05GLOBEClearside Biomedical to Report First Quarter 2024 Financial..
2024/4/1620:05GLOBEClearside Biomedical Appoints Seasoned Biotechnology..
2024/4/0220:05GLOBEClearside Biomedical to Participate in Fireside Chat at the..
2024/3/1820:05GLOBEClearside Biomedical Appoints Victor Chong, M.D., MBA as..
2024/3/1305:05GLOBEClearside Biomedical Announces Fourth Quarter and Full Year..
2024/2/2921:05GLOBEClearside Biomedical to Report Fourth Quarter and Full Year..
2024/2/0907:05EDGAR2Form 8-K - Current report
2024/2/0906:52EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/0722:00GLOBEClearside Biomedical Announces Pricing of $15 Million..
2024/2/0206:01EDGAR2Form 8-K - Current report
2024/1/2008:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2005:04EDGAR2Form 144 - Report of proposed sale of securities
2023/12/2906:10EDGAR2Form 8-K - Current report
2023/12/1421:05GLOBEClearside Biomedical Reports Significant Progress in ODYSSEY..
2023/11/1406:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1406:10EDGAR2Form 8-K - Current report
2023/11/1406:05GLOBEClearside Biomedical Announces Third Quarter 2023 Financial..
2023/11/0821:05GLOBEClearside Biomedical to Participate in Fireside Chat at the..
2023/11/0806:20GLOBEClearside Biomedical’s Versatile Suprachoroidal Injection..
2023/11/0401:01EDGAR2Form 8-K - Current report
2023/11/0401:00GLOBEBioCryst and Clearside Biomedical Enter Partnership to..
2023/11/0220:05GLOBEClearside Biomedical Announces Presentations at the American..
2023/11/0120:05GLOBEClearside Biomedical Completes Recruitment in ODYSSEY Phase..
2023/10/3120:05GLOBEClearside Biomedical to Report Third Quarter 2023 Financial..
2023/10/1620:05GLOBEClearside Biomedical Positive OASIS and Extension Study Data..
2023/10/0422:00GLOBEClearside Biomedical Announces Advancement of XIPERE® in..
2023/10/0405:35GLOBEClearside Biomedical to Participate in a Panel Discussion at..
2023/9/3005:46EDGAR2Form 8-K - Current report
2023/9/2605:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2305:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2105:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1920:05GLOBEClearside Biomedical to Participate in Panel Discussion at..
2023/9/1407:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1505:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1505:11EDGAR2Form 8-K - Current report
2023/8/1505:05GLOBEClearside Biomedical Announces Second Quarter 2023 Financial..
2023/8/0305:30GLOBEClearside Biomedical to Participate in Upcoming Investor..
2023/8/0120:05GLOBEClearside Biomedical to Report Second Quarter 2023 Financial..
2023/7/3120:05GLOBEClearside Biomedical Highlights Excellent Safety Profile of..
2023/7/2020:05GLOBEClearside Biomedical’s Suprachoroidal Injection Platform to..
2023/7/1720:05GLOBEClearside Biomedical Announces Enrollment of Multiple..
2023/7/1205:05GLOBEClearside Biomedical CEO George Lasezkay to Present at the..
2023/7/1020:05GLOBEClearside Biomedical Asia-Pacific Partner Arctic Vision..
2023/6/0120:05GLOBEClearside Biomedical Opens Enrollment in ODYSSEY Phase 2b..
2023/5/1120:05GLOBEClearside Biomedical Announces First Quarter 2023 Financial..
2023/5/1005:30GLOBEClearside Biomedical to Participate in a Fireside Chat at..

最近閲覧した銘柄

Delayed Upgrade Clock